Citigroup »

Beam Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.5M 237k 27.22
2023-09-30 $4.8M 198k 24.05
2023-03-31 $7.8M 255k 30.62
2022-12-31 $5.8M 149k 39.11
2022-09-30 $6.4M 135k 47.08
2021-12-31 $7.1M 87k 81.48
2021-03-31 $3.7M 46k 80.04
2020-12-31 $982k 12k 81.63
2020-09-30 $52k 2.1k 24.69
2020-06-30 $111k 4.0k 28.04
2020-03-31 $63k 3.5k 17.90